Skip to main content
Articles & Publications , Dr. Asma Patel , John McDermott

Introducing Translational Pharmaceutics: Asma Patel and John McDermott

Small Molecule Development & Manufacturting at Quotient Sciences

In this article by the Medicine Maker, Asma Patel and John McDermott talk about the complexities of developing modified release formulations.

These formulations allow more control over drug release in the gastrointestinal (GI) tract, providing benefits such as prolonged drug plasma levels, reduced dosing frequency, and targeted delivery. To optimize drug delivery, a “translational pharmaceutics” approach evaluates a “design space” within clinical studies, aligning with ICH Q8 quality-by-design principles.

Continue reading the article on Medicine Maker.

Latest news from Quotient Sciences

More News
News & Announcements, Articles & Publications, Thierry Van Nieuwenhove Thierry Van Nieuwenhove on the Future of CDMO Partnerships By: Thierry Van Nieuwenhove
Read More
News & Announcements, Translational Pharmaceutics®, Articles & Publications BioPharm International interviews Helen Baker about how Quotient Sciences is optimizing drug development
Read More
Get in touch
Humanity can't afford to wait, so neither can we.